← Leaderboards
Raymond Malfavon-Borja
Fred Hutchinson Cancer Research Center
$107,642
Attributed
$107,642
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $40.2K · FY2009–14$50K$37.5K$25K$12.5K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$107,642 · 2
By mechanism
F31$67,396 · 1
F32$40,246 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Adam P. Geballe$12,800,633
- Molly Ohainle$2,161,250
- Maxine L Linial$15,618,506
- Harmit S Malik$1,008,625
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusHost DefensePrimatesDesignInsightGenomeInfectionPressureRetroviridaeBioinformaticsPublic Health RelevanceProteinsEvolutionCellsCell CommunicationAsiansCebidaeCareer DevelopmentFusion GeneGene FusionConflict (Psychology)CareerCapsid ProteinsCommunities
Grant awards (3)
Anti-Retroviral Activity of Human Endogenous Retroviruses$40,246
F32 · FY2014 · AI · contact PI
The Role of CyclophilinA in the Evolution of Retroviral Restriction$33,800
F31 · FY2010 · AI · contact PI
The Role of CyclophilinA in the Evolution of Retroviral Restriction$33,596
F31 · FY2009 · AI · contact PI